You have 1 free searches left this month | for more free features.

Glyburide

Showing 126 - 141 of 141

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metabolics Diabetes Nos Trial in Worldwide (Muraglitazar)

Completed
  • Metabolics Diabetes Nos
  • Anniston, Alabama
  • +149 more
Sep 10, 2010

Healthy Trial in Sainte-Foy (Glyburide/Metformin 5 mg/500 mg Tablets, Glucovance® 5 mg/500 mg Tablets)

Completed
  • Healthy
  • Glyburide/Metformin 5 mg/500 mg Tablets
  • Glucovance® 5 mg/500 mg Tablets
  • Sainte-Foy, Quebec, Canada
    Anapharm Inc.
Sep 1, 2009

Healthy Trial in Sainte-Foy (Glyburide/Metformin 5 mg/500 mg Tablets, Glucovance® 5 mg/500 mg Tablets)

Completed
  • Healthy
  • Glyburide/Metformin 5 mg/500 mg Tablets
  • Glucovance® 5 mg/500 mg Tablets
  • Sainte-Foy, Quebec, Canada
    Anapharm Inc.
Sep 1, 2009

Diabetes, Type 2 Trial in Beijing (Insulin Glargine, Glyburide, Glyclazide)

Completed
  • Diabetes Mellitus, Type 2
  • Insulin Glargine
  • +5 more
  • Beijing, China
    Sanofi-Aventis
Sep 14, 2009

Diabetes Trial in Taichung (Acarbose)

Completed
  • Diabetes Mellitus
  • Taichung, Taiwan
    Taichung Veterans General Hospital
May 11, 2010

Hypoglycemia Trial in Jerusalem (glucagon)

Completed
  • Hypoglycemia
  • Jerusalem, Israel
    Share Zedek Medical Center
May 27, 2009

Type 2 Diabetes Trial in Chicago (Glipizide, Glipizide and Glargine)

Completed
  • Type 2 Diabetes
  • Chicago, Illinois
    John H Stroger Hospital Of Cook County
Aug 11, 2008

Type 2 Diabetes Patients Switched From Sulfonylurea With

Completed
  • Type 2 Diabetes Mellitus
    • Taipei, Taiwan
      National Taiwan university hospital
    Oct 9, 2007

    Type 2 Diabetes Trial in Ann Arbor, Toledo (Rosiglitazone, Glyburide)

    Completed
    • Type 2 Diabetes
    • Ann Arbor, Michigan
    • +1 more
    Nov 8, 2007

    Diabetes, Arterial Stiffness Trial in Zrifin (sitagliptin, glibenclamide)

    Unknown status
    • Diabetes Mellitus
    • Arterial Stiffness
    • Zrifin, Israel
      Department of Internal Medicine A , Research & Development unit
    Jun 12, 2008

    Type 2 Diabetes Trial in Worldwide (Tesaglitazar, Glibenclamide)

    Terminated
    • Type 2 Diabetes
    • Antwerpen, Belgium
    • +65 more
    Mar 14, 2008

    Type 2 Diabetes Trial in Worldwide (Tesaglitazar 0.5 or 1 mg, Glibenclamide 2.5, 5, 10 or 15 mg)

    Terminated
    • Type 2 Diabetes
    • Tesaglitazar 0.5 or 1 mg
    • Glibenclamide 2.5, 5, 10 or 15 mg
    • Adelaide, Australia
    • +83 more
    Mar 14, 2008

    Gestational Diabetes, Type 2 Diabetes, Pregnancy Trial in Chattanooga (Insulin versus glucovance (glyburide/metformin))

    Unknown status
    • Gestational Diabetes
    • +2 more
    • Insulin versus glucovance (glyburide/metformin)
    • Chattanooga, Tennessee
      Regional Obstetrical Consultants
    Apr 19, 2007

    Type 1 Diabetes Trial in London (Glibenclamide)

    Unknown status
    • Type 1 Diabetes Mellitus
    • London, United Kingdom
      King's College Hospital NHS Foundation Trust
    May 10, 2007

    Clinical Course of Diabetic Nephropathy: Population-Based Study

    Unknown status
    • Diabetes
    • +2 more
    • Rosiglitasone (retrospective observation)
    • Zerifin,, Israel
      Clalit Health Cervices, Central District
    Jul 6, 2007

    Ischemic Injury and Ischemic Preconditioning in Diabetes

    Completed
    • Diabetes Mellitus, Insulin-Dependent
    • Ischemia-Reperfusion Injury
    • Ischemic preconditioning
    • +5 more
    • Nijmegen, Gelderland, Netherlands
      Clinical Research Centre Nijmegen; Radboud University Nijmegen M
    Apr 4, 2007